Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer
Following interval cytoreductive surgery, despite optimal complete cytoreductive surgery, a pathological PCI of 8 is a poor prognostic indicator of survival and may serve as a surrogate clinical marker for guiding clinicians in adjuvant treatment, especially in resource-driven settings in the real world.
Authors
- S. Deepika (ORCID: https://orcid.org/0009-0003-5023-1050)
- Snita Sinukumar
- Dileep Damodaran (ORCID: https://orcid.org/0000-0002-0367-994X)
- Sanjay Piplani
Institutions
- Regional Cancer Center, Thiruvananthapuram (IN)
- Jehangir Hospital (IN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-08-20
- DOI
- https://doi.org/10.3389/fonc.2024.1458019
- Citations
- 4
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.15